자유게시판 글답변
본문 바로가기
회원가입
로그인
검색보다 편한
즐겨찾기 추가하기
사이트 내 전체검색
검색어
필수
메인메뉴
병원소개
인사말
의료진 소개
케임씨잉 정보
케임씨잉 소식
첨단장비 소개
기타장비 소개
증명원
제휴업체
행복나눔
아프리카 의료봉사
수술클리닉
웨이브 프론트
크리스탈 Plus 라식
프리미엄 라섹
NEW 아마리스 750s
라식 / 라섹
백내장 / 노안교정술
초고도근시 교정술
눈종합검사
수술전후주의사항
원데이라식
특수콘텍트클리닉
하드렌즈
소프트렌즈
드림렌즈(OK렌즈)
CRT 드림렌즈
망막클리닉
황반변성
당뇨망막병증
비문증
망막박리
중심성 망막혈관폐쇠증
망막혈관폐쇠증
포도막염
OPTOS DAYTONA
소아클리닉
소아시력교정
소아약시
소아사시
안질환클리닉
안구건조증
녹내장
결막염
익상편 / 결막점
VDT증후군
원추각막
눈물관 클리닉
수술체험기
가상수술체험
수술체험기
수술후기
예약/상담
온라인상담
온라인 예약
자주 묻는 질문
설문조사
유성케임씨잉안과의원을 오실때 교통수단 무엇을 이용하세요?
자가차량
버스
택시
도보
자유게시판 글답변
이름
필수
비밀번호
필수
이메일
홈페이지
분류
필수
선택하세요
정보
이야기
칭찬
불만
제목
필수
내용
필수
웹에디터 시작
> > > SV388 is a cell line derived from the murine fibroblast cells that has gained significant attention in cancer research. Initially isolated in the early 1970s, SV388 is characterized by its unique properties that make it a valuable model for studying the biology of cancer and the underlying mechanisms of tumor progression. The purpose of this article is to provide an overview of the characteristics, applications, and significance of SV388 in cancer research.<br/><br/>At its core, SV388 is a transformed cell line that originates from Swiss mice. The transformation process involves the incorporation of viral oncogenes, which leads to alterations in the normal cellular pathways and enables unchecked cell proliferation. SV388 cells exhibit features such as anchorage-independent growth, increased metabolic activity, and the ability to form tumors in immunocompromised mouse models, which are hallmarks of cancerous cells. These characteristics make SV388 an ideal in vitro model for studying the mechanisms of tumorigenesis, cell signaling pathways, and the effects of potential therapeutic agents.<br/><br/><img src="https://plus.unsplash.com/premium_photo-1710347001600-411ae83fb6a4?ixid=M3wxMjA3fDB8MXxzZWFyY2h8MTd8fHNhYnVuZyUyMGF5YW18ZW58MHx8fHwxNzQ0MzA5NjQ3fDA\u0026ixlib=rb-4.0.3">One of the primary advantages of using SV388 in research is its well-documented genetic profile. The line has been extensively characterized, providing researchers with a wealth of information regarding its genomic and proteomic features. This information is crucial for the design of experiments aimed at identifying novel therapeutic targets or evaluating the efficacy of existing treatments. Furthermore, the reproducibility of results obtained from SV388 cells allows for more reliable translation of findings to in vivo studies and clinical applications.<br/><br/>SV388 has been utilized in various contexts within the cancer research community. For instance, it serves as a platform for high-throughput screening of small molecules that may inhibit cell growth or induce apoptosis in cancer cells. Researchers have explored the efficacy of numerous compounds ranging from traditional chemotherapeutics to novel targeted therapies on SV388, often leading to valuable insights into drug resistance mechanisms. Moreover, SV388 has been instrumental in elucidating signaling pathways involved in cancer progression, including studies focused on the PI3K-AKT-mTOR and MAPK pathways.<br/><br/>In addition to its use in testing therapeutic agents, SV388 has also played a crucial role in the identification of biomarkers for cancer diagnosis and prognosis. By comparing the gene expression profiles of SV388 to other cell lines or primary tumor samples, researchers can uncover potential biomarkers that may provide insights into tumor heterogeneity and patient outcomes. This aspect is particularly important as personalized medicine continues to evolve, emphasizing the need for biomarkers that can predict individual responses to treatment.<br/><br/>However, despite its numerous advantages, researchers must approach the use of SV388 with caution. As with any cell line, there are limitations and concerns related to genetic drift, microbiological contamination, and the comparison to in vivo systems. Therefore, it remains vital for res > >
웹 에디터 끝
자동등록방지
자동등록방지
숫자음성듣기
새로고침
자동등록방지 숫자를 순서대로 입력하세요.
취소
회사소개
개인정보취급방침
서비스이용약관
모바일 버전으로 보기
상단으로
대전광역시 유성구 계룡로 105
(구. 봉명동 551-10번지) 3, 4층 | 대표자 :
김형근, 김기형 |
사업자 등록증 :
314-25-71130
대표전화 :
1588.7655
| 팩스번호 :
042.826.0758
Copyright ©
CAMESEEING.COM
All rights reserved.
접속자집계
오늘
4,013
어제
5,045
최대
16,322
전체
5,071,033
-->